1Lee HC, Suh DJ. Lamivudine therapy for decompensated liver cirrhosis related to hepatitis B virus infection. Intervirology,2003,46: 388-393.
2Markowitz JS, Martin P, Conrad AJ, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology, 1998,28:585-589.
3Naumann UP, Langrehr JM, Naumann U, et al. Impact of HLA-compatibilities in patients undergoing liver transplantation for HBV-cirrhosis. Clin Transplant,2002,16:122-129.
4Fontana RJ. Management of decompensated HBV cirrhosis: lamivudine and beyond. Am J Gastroenterol,2004,99: 64-67.
同被引文献11
1Shi-Chun Lu, Lu-Nan Yan, Bo Li, Tian-Fu Wen, Ji-Chun Zhao, Nan-Sheng Cheng, Chong Liu, Jun Liu, Xiao-Bo Wang, Xiao-Dong Li, Shan Qin, Lian-Shan Zhao, Bin-Jun Lei and Xiu-Hui Zhang Chengdu, China Department of Surgery ,Viral Hepa- titis Research Center ,Department of Pathology , West China Hospital, Sichuan University, Cheng- du 610041 , China.Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2004,3(1):26-32. 被引量：9
